Carotid Intimal Medial Thickness in Human Immunodeficiency Virus-Infected Women: Effects of Protease Inhibitor Use, Cardiac Risk Factors, and the Metabolic Syndrome | Zendy

Stine Johnsen | Zendy; Sara Dolan | Zendy; Kathleen V. Fitch | Zendy; Jenna R. Kanter | Zendy; Linda Hemphill | Zendy; Jean M. Connelly | Zendy; Robert S. Lees | Zendy; Hang Lee | Zendy; Steve Grinspoon | Zendy

Open Access

Carotid Intimal Medial Thickness in Human Immunodeficiency Virus-Infected Women: Effects of Protease Inhibitor Use, Cardiac Risk Factors, and the Metabolic Syndrome

Author(s) -

Stine Johnsen,

Sara Dolan,

Kathleen V. Fitch,

Jenna R. Kanter,

Linda Hemphill,

Jean M. Connelly,

Robert S. Lees,

Hang Lee,

Steve Grinspoon

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-1140

Subject(s) - medicine , body mass index , metabolic syndrome , subclinical infection , population , waist , gastroenterology , cardiology , obesity , environmental health

Little is known regarding carotid intimal medial thickness (IMT) in HIV-infected women and the risk factors for subclinical atherosclerosis in this population, including antiretroviral therapy and the metabolic syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research